IRWDIronwood Pharmaceuticals, Inc.
$3.86+154% 1Y
$3.86
$1.4352 weeks$5.39
The financials
Ironwood Pharmaceuticals, Inc. by the numbers
Ironwood Pharmaceuticals, Inc. (IRWD) reported revenue of $113M in Q2 2026 (quarter ended Jun 30, 2026), up 33% from the same quarter a year earlier. That came with net income of $51M (45% of revenue). For the full year FY2025, revenue was $296M (−16% year on year) and net income $24M. The next results filing is expected around Nov 9, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $113M | $85M | +33% |
| Operating income | $79M | $45M | +75% |
| Net income | $51M | $24M | +117% |
| Diluted EPS | $0.31 | $0.14 | +121% |
Drug Manufacturers, Specialty & Generic
Ranks #18 of 41 by RyuScore